-
Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trialAbdin A, Pöss J, Thiele H et al. -
Wearable Cardioverter-Defibrillator after Myocardial InfarctionOlgin JE, Pletcher MJ, VEST Investigators et al.
-
Impact of the US Food and Drug Administration–Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial InfarctionMR Gimenez, P Badertscher, R Twerenbold et al.
-
Long-Term Coronary Functional Assessment of the Infarct-Related Artery Treated With Everolimus-Eluting Bioresorbable Scaffolds or Everolimus-Eluting Metallic Stents: Insights of the TROFI II TrialGomez-Lara J, Brugaletta S, Ortega-Paz L et al.
-
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term OutcomesSamman Tahhan A, Sandesara P, Quyyumi AA et al.
-
Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trialGershlick AH, Khan JN, Kelly DJ et al.
-
What's new in the Fourth Universal Definition of Myocardial infarction?Thygesen K
-
The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial InfarctionMaznyczka AM, Oldroyd KG, Berry C et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
